Nigeria agriculture, meals safety and dietary consumption haven’t been exempted from the disruptions in numerous sectors round the world because of the outbreak of COVID-19. The nation first skilled the outbreak on February 27, 2020, and the expertise since then has proven unfavourable results not solely on the socioeconomic situations but in addition on agriculture, meals safety and dietary consumption. Long time period in-depth evaluation of the results of this pandemic on meals safety and dietary consumption utilizing quantitative information remains to be very tough because of paucity of information and the nice degree of the improbability of the trajectory of the unfold of the Virus.
This examine is a fast evaluation of the brief and long-term potential results of the illness. It relied on a evaluation of scenario experiences particularly by the Nigeria Centre of Disease Control and different experiences round the world on COVID-19, private observations, and public opinion through cell phone survey of Lagos and Oyo States, Nigeria. Findings present that meals demand and provide shocks attributable to COVID-19 outbreak have an effect on agriculture, meals and dietary consumption negatively by means of COVID-19 insurance policies. It results in a discount in family revenue coupled with hike in meals costs.
Owing to the Nigeria’s crude farming apply, there was a shortage of employed labour required for manufacturing course of throughout 2020 farming season. This implies a excessive probability of low output and additional surge in meals costs in the future. Food entry was additionally compromised with the accumulation of unsold recent produce by the smallholder farmers and the low wage earners throughout motion restrictions and of loss revenue because of this of worldwide border closure.
Food and dietary consumption is affected as individuals are shifting diets to extra reasonably priced and low high quality meals, whereas meals stability will not be assured because of market insecurity, prompting a unprecedented degree of indecision. The examine concludes that the shock of COVID-19 will not be solely a requirement administration drawback however a multidimensional disaster requiring financial, fiscal, and well being coverage responses with international collaboration and cooperation.
Innovations in nanoscience for the sustainable improvement of meals and agriculture with implications on well being and surroundings
A fast improve in world inhabitants is resulting in the rise in international demand of meals and agriculture (agri) merchandise. Nanotechnology and its functions have emerged as one of the most pioneering and promising know-how for reworking typical meals and agri industries, with the intention of sustainable farming, enhancing the meals safety, high quality and security which might revolutionize the meals and agri industries. Current developments in nanotechnology have led to the new paths progressively and bringing the radical adjustments the manner meals is perceived all through the farming, transportation, processing, packaging, storage, monitoring and consumption. This evaluation brings the present updates on novel nanomaterials in meals and agri industries.
Emphasis is given on the significance of nanotechnological functions, providing full meals options from farm to fork; together with nutraceutical and practical meals, enhancing bioavailability, effectivity, dietary standing, nano-additives, meals texture, coloration, style and packaging. Agricultural sector additionally witnessed a number of nano-based merchandise, akin to nano-fertilizer, nano-pesticide, nano progress promoters and many extra for the improvement of sustainable farming and crop enchancment.
Despite of quite a few benefits of nanotechnology, there are nonetheless toxicity challenges, security issues, which must be addressed and calls for transformations in regulatory insurance policies. Rapid improvement is projected to remodel a number of meals and agri sectors, with fast improve in market stake and funding. Government businesses, non-public analysis facilities in addition to academicians are additionally coming collectively to discover the advantages of nanotechnology to enhance meals shortage in the coming years.
Technologies to ship meals and local weather safety by means of agriculture
Agriculture is a serious contributor to environmental degradation and local weather change. At the identical time, a rising human inhabitants with altering dietary preferences is driving ever rising demand for meals. The want for pressing reform of agriculture is widely known and has resulted in a quantity of bold plans. However, there may be credible proof to counsel that these are unlikely to fulfill the twin goals of conserving the improve in international temperature inside the goal of 2.0 °C above preindustrial ranges set out in the Paris Agreement and delivering international meals safety.
Here, we focus on a collection of technological choices to result in change in agriculture for delivering meals safety and offering a number of routes to the elimination of CO2 from the ambiance. These applied sciences embody the use of silicate modification of soils to sequester atmospheric CO2, agronomy applied sciences to extend soil natural carbon, and high-yielding resource-efficient crops to ship elevated agricultural yield, thus liberating land that’s much less fitted to intensive cropping for land use practices that can additional improve carbon storage. Such alternate options embody much less intensive regenerative agriculture, afforestation and bioenergy crops coupled with carbon seize and storage applied sciences.
(Broken) Promises of Sustainable Food and Agriculture by means of New Biotechnologies: The CRISPR Case
In current years, the improvement of various CRISPR-based applied sciences has revolutionized genome manipulation and enabled a broad scientific neighborhood in trade, academia, and past to redefine analysis and improvement for biotechnology merchandise encompassing meals, agriculture, and medication. CRISPR-based genome enhancing affords large alternatives in agriculture for the breeding of crops and livestock throughout the meals provide chain that would profit bigger parts of the inhabitants in comparison with CRISPR functions in medication, for instance by serving to to feed a rising international inhabitants, attain sustainability targets, and presumably mitigate the results of local weather change.
These guarantees come alongside issues of dangers and adversarial impacts related to CRISPR-based genome enhancing and issues that governance methods which might be unwell geared up or not effectively suited to judge these dangers. The worldwide neighborhood will proceed to assemble, in a number of venues, in the coming years to debate these issues. At the identical time, accountable analysis and innovation paradigms additionally promise to judge the dangers and advantages higher whereas incorporating broad stakeholder engagement throughout the analysis and improvement course of.
Serum Amyloid A Protein (SAA1) Antibody |
20-abx109401 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Serum amyloid A-4 protein |
AP87464 |
SAB |
1mg |
EUR 2640 |
|
Serum amyloid A-4 protein |
AP88075 |
SAB |
1mg |
EUR 2640 |
|
Serum amyloid A-4 protein |
AP78756 |
SAB |
1mg |
EUR 2640 |
|
Serum amyloid A protein Polyclonal Antibody |
42575 |
SAB |
100μg |
EUR 390 |
Serum Amyloid A-1 Protein (SAA1) Antibody |
abx237572-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
Serum Amyloid A-2 Protein (SAA2) Antibody |
abx237573-100ug |
Abbexa |
100 ug |
EUR 661.2 |
|
Serum Amyloid A-1 Protein (SAA1) Antibody |
abx413456-1ml |
Abbexa |
1 ml |
EUR 410.4 |
|
Serum Amyloid A-1 Protein (SAA1) Antibody |
abx414889-02mg |
Abbexa |
0.2 mg |
EUR 678 |
|
Serum Amyloid A-1 Protein (SAA1) Antibody |
20-abx001392 |
Abbexa |
-
EUR 493.20
-
EUR 710.40
-
EUR 218.40
-
EUR 376.80
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Serum Amyloid A Protein (SAA1) Antibody (HRP) |
20-abx108750 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Serum Amyloid A Protein (SAA1) Antibody (HRP) |
20-abx109024 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Serum Amyloid A Protein (SAA1) Antibody (FITC) |
20-abx107330 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Serum Amyloid A Protein (SAA1) Antibody (FITC) |
20-abx107606 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Serum Amyloid A Protein (SAA1) Antibody (Biotin) |
20-abx105915 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Serum Amyloid A Protein (SAA1) Antibody (Biotin) |
20-abx106191 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Serum amyloid A-1 protein Polyclonal Antibody |
42575-100ul |
SAB |
100ul |
EUR 399.6 |
Serum Amyloid A-1 Protein (SAA1) Antibody Pair |
abx117593-1pair5x96wellplates |
Abbexa |
1 pair (5x96 well plates) |
EUR 1212 |
|
Serum amyloid A protein |
30-1380 |
Fitzgerald |
500 ug |
EUR 418.8 |
Description: Recombinant Serum amyloid A protein |
Serum amyloid A protein |
AP87704 |
SAB |
1mg |
EUR 2640 |
|
Serum amyloid A protein |
AP78712 |
SAB |
1mg |
EUR 2640 |
|
Serum amyloid A-2 protein |
AP87495 |
SAB |
1mg |
EUR 2640 |
|
Serum amyloid A-1 protein |
AP87649 |
SAB |
1mg |
EUR 2640 |
|
Serum amyloid A-2 protein |
AP87666 |
SAB |
1mg |
EUR 2640 |
|
Serum amyloid A-3 protein |
AP87674 |
SAB |
1mg |
EUR 2640 |
|
Serum amyloid A-1 protein |
AP78713 |
SAB |
1mg |
EUR 2640 |
|
Serum amyloid A-1 protein Polyclonal Conjugated Antibody |
C42575 |
SAB |
100ul |
EUR 476.4 |
Human Serum Amyloid A-4 Protein (SAA4) Protein |
20-abx262355 |
Abbexa |
-
EUR 393.60
-
EUR 7676.40
-
EUR 276.00
|
|
|
Human Serum Amyloid A-4 (SAA4) Antibody |
13031-05011 |
AssayPro |
150 ug |
EUR 260.4 |
Serum amyloid A protein (His tag) |
80R-1189 |
Fitzgerald |
100 ug |
EUR 308.4 |
Description: Purified recombinant Human Serum amyloid A protein |
Serum Amyloid A (SAA) Antibody |
20-abx174524 |
Abbexa |
|
|
|
Serum Amyloid A (SAA) Antibody |
20-abx178371 |
Abbexa |
-
EUR 477.60
-
EUR 159.60
-
EUR 1312.80
-
EUR 644.40
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Serum Amyloid A (SAA) Antibody |
20-abx178372 |
Abbexa |
|
|
|
Serum Amyloid A (SAA) Antibody |
20-abx178374 |
Abbexa |
|
|
|
Serum Amyloid A (SAA) Antibody |
20-abx132400 |
Abbexa |
-
EUR 376.80
-
EUR 944.40
-
EUR 493.20
-
EUR 184.80
-
EUR 309.60
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Serum Amyloid A (SAA) Antibody |
abx022449-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
Serum Amyloid A (SAA) Antibody |
abx022450-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
Serum Amyloid A (SAA) Antibody |
abx022451-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
Serum Amyloid A (SAA) Antibody |
abx022452-05mg |
Abbexa |
0.5 mg |
EUR 1680 |
|
Serum Amyloid A (SAA) Antibody |
20-abx101239 |
Abbexa |
-
EUR 477.60
-
EUR 159.60
-
EUR 1328.40
-
EUR 644.40
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Serum Amyloid A (SAA) Antibody |
20-abx101240 |
Abbexa |
-
EUR 493.20
-
EUR 159.60
-
EUR 1362.00
-
EUR 661.20
-
EUR 376.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Serum Amyloid A (SAA) Antibody |
20-abx101241 |
Abbexa |
-
EUR 510.00
-
EUR 159.60
-
EUR 1412.40
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Serum Amyloid A (SAA) Antibody |
48336-100ul |
SAB |
100ul |
EUR 399.6 |
Serum Amyloid A (SAA) Antibody |
48336-50ul |
SAB |
50ul |
EUR 286.8 |
Serum Amyloid A (SAA) Antibody |
48336 |
SAB |
100ul |
EUR 429 |
Cat Serum amyloid A protein (SAA1) |
1-CSB-YP020656CA |
Cusabio |
-
EUR 814.80
-
EUR 402.00
-
EUR 2606.40
-
EUR 1261.20
-
EUR 1730.40
-
EUR 522.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Cat Serum amyloid A protein(SAA1),partial expressed in Yeast |
Cat Serum amyloid A protein (SAA1) |
1-CSB-EP020656CA |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Cat Serum amyloid A protein(SAA1),partial expressed in E.coli |
Dog Serum amyloid A protein (SAA1) |
1-CSB-EP020656DO |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Dog Serum amyloid A protein(SAA1) expressed in E.coli |
rec Serum Amyloid A Protein (human) |
H-1724.0010 |
Bachem |
10.0µg |
EUR 194.4 |
Description: Sum Formula: C522H759N155O157S3; CAS# [1927910-97-1] |
rec Serum Amyloid A Protein (human) |
H-1724.0050 |
Bachem |
50.0µg |
EUR 457.2 |
Description: Sum Formula: C522H759N155O157S3; CAS# [1927910-97-1] |
Horse Serum amyloid A protein (SAA1) |
1-CSB-EP020656HO |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Horse Serum amyloid A protein(SAA1) expressed in E.coli |
Horse Serum amyloid A protein (SAA1) |
1-CSB-EP020656HOb0 |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Horse Serum amyloid A protein(SAA1) expressed in E.coli |
Bovine Serum amyloid A protein (SAA1) |
1-CSB-EP020656BO |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Bovine Serum amyloid A protein(SAA1) expressed in E.coli |
Bovine Serum amyloid A protein (SAA1) |
1-CSB-EP020656BOb3 |
Cusabio |
-
EUR 733.20
-
EUR 370.80
-
EUR 2192.40
-
EUR 1126.80
-
EUR 1461.60
-
EUR 476.40
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Bovine Serum amyloid A protein(SAA1) expressed in E.coli |
Recombinant Mouse Serum amyloid A-4 protein (Saa4) |
CSB-EP020659MO |
Cusabio |
8881 mg |
Ask for price |
Amyloid A, Serum (SAA) Protein |
abx061449-1mg |
Abbexa |
1 mg |
EUR 1220.4 |
|
Cow Serum amyloid A-4 protein (SAA4) ELISA Kit |
abx514753-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
ELISA kit for Human Serum amyloid A-4 protein |
EK2590 |
SAB |
96 tests |
EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Serum amyloid A-4 protein in samples from serum, plasma, tissue homogenates and other biological fluids. |
Amyloid A, Serum (SAA) Antibody |
abx023988-1mg |
Abbexa |
1 mg |
EUR 1262.4 |
|
Amyloid A, Serum (SAA) Antibody |
abx023989-1mg |
Abbexa |
1 mg |
EUR 1262.4 |
|
Amyloid A, Serum (SAA) Antibody |
abx023990-1mg |
Abbexa |
1 mg |
EUR 1262.4 |
|
Amyloid A, Serum (SAA) Antibody |
abx023991-1mg |
Abbexa |
1 mg |
EUR 1262.4 |
|
Amyloid A, Serum (SAA) Antibody |
abx024166-1mg |
Abbexa |
1 mg |
EUR 794.4 |
|
Cow Serum Amyloid A (SAA) Protein |
20-abx655047 |
Abbexa |
-
EUR 744.00
-
EUR 326.40
-
EUR 2230.80
-
EUR 878.40
-
EUR 543.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Dog Serum Amyloid A (SAA) Protein |
abx670151-01mg |
Abbexa |
0.1 mg |
EUR 1144.8 |
|
Cat Serum Amyloid A (SAA) Protein |
abx670164-01mg |
Abbexa |
0.1 mg |
EUR 1144.8 |
|
Human Serum amyloid A-4 protein (SAA4) ELISA Kit |
abx250406-96tests |
Abbexa |
96 tests |
EUR 904.8 |
|
Human Serum amyloid A-4 protein (SAA4) ELISA Kit |
abx514754-96tests |
Abbexa |
96 tests |
EUR 904.8 |
|
Mouse Serum amyloid A-4 protein (SAA4) ELISA Kit |
abx514755-96tests |
Abbexa |
96 tests |
EUR 886.8 |
|
Human Serum amyloid A-4 protein(SAA4) ELISA kit |
CSB-EL020659HU-24T |
Cusabio |
1 plate of 24 wells |
EUR 198 |
|
Description: Quantitativesandwich ELISA kit for measuring Human Serum amyloid A-4 protein (SAA4) in samples from serum, plasma, tissue homogenates. A new trial version of the kit, which allows you to test the kit in your application at a reasonable price. |
Human Serum amyloid A-4 protein(SAA4) ELISA kit |
1-CSB-EL020659HU |
Cusabio |
-
EUR 964.80
-
EUR 6118.80
-
EUR 3244.80
|
- 1 plate of 96 wells
- 10 plates of 96 wells each
- 5 plates of 96 wells each
|
|
Description: Quantitativesandwich ELISA kit for measuring Human Serum amyloid A-4 protein(SAA4) in samples from serum, plasma, tissue homogenates. Now available in a cost efficient pack of 5 plates of 96 wells each, conveniently packed along with the other reagents in 5 separate kits. |
Mouse Saa4/ Serum amyloid A-4 protein ELISA Kit |
E1304Mo |
Sunlong |
1 Kit |
EUR 758.4 |
Mouse Serum amyloid A- 4 protein, Saa4 ELISA KIT |
ELI-40813m |
Lifescience Market |
96 Tests |
EUR 1038 |
Human SAA4/ Serum amyloid A-4 protein ELISA Kit |
E2208Hu |
Sunlong |
1 Kit |
EUR 726 |
Human SAA4(Serum amyloid A-4 protein) ELISA Kit |
EH1155 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml |
Human Serum amyloid A- 4 protein, SAA4 ELISA KIT |
ELI-21759h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Human SAA4(Serum amyloid A-4 protein) ELISA Kit |
EKF60404-5x96T |
Biomatik Corporation |
5x96T |
EUR 2693.25 |
Mouse Serum amyloid A-4 protein (SAA4) ELISA Kit |
RK13666 |
Abclonal |
96T |
EUR 280 |
Human Serum amyloid A-4 protein (SAA4) ELISA Kit |
RK11383 |
Abclonal |
96T |
EUR 280 |
Human Serum amyloid A-4 protein (SAA4) ELISA Kit |
AE20835HU-48Tests |
Abebio |
48 Tests |
EUR 325 |
|
Description: Human (Homo sapiens) |
Human Serum amyloid A-4 protein (SAA4) ELISA Kit |
AE20835HU-96Tests |
Abebio |
96 Tests |
EUR 610 |
|
Description: Human (Homo sapiens) |
Mouse Serum amyloid A-4 protein(SAA4) Elisa kit |
EK731584 |
AFG Bioscience LLC |
96 Wells |
EUR 0.8 |
Human Serum amyloid A-4 protein(SAA4) Elisa Kit |
EK700039 |
AFG Bioscience LLC |
96 Wells |
EUR 0.37 |
Human Serum amyloid A-4 protein (SAA4) ELISA Kit |
KTE60753-96T5 |
Abbkine |
96 T×5 |
EUR 2629 |
Description: This Human Serum amyloid A-4 protein (SAA4) ELISA Kit employs a two-site sandwich ELISA to quantitate SAA4. |
Human Serum amyloid A-4 protein (SAA4) ELISA Kit |
KTE60753-96T50 |
Abbkine |
96 T×50 |
EUR 24569 |
Description: This Human Serum amyloid A-4 protein (SAA4) ELISA Kit employs a two-site sandwich ELISA to quantitate SAA4. |
Human Serum amyloid A-4 protein(SAA4) ELISA kit |
EKC35541-5x96T |
Biomatik Corporation |
5x96T |
EUR 3637.08 |
Serum Amyloid A (SAA) Antibody (PE) |
20-abx274642 |
Abbexa |
-
EUR 543.60
-
EUR 292.80
-
EUR 1579.20
-
EUR 760.80
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Bovine Serum amyloid A- 4 protein, SAA4 ELISA KIT |
ELI-20131b |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Serum Amyloid A (SAA) Antibody (APC) |
20-abx178373 |
Abbexa |
|
|
|
Serum Amyloid A (SAA/2868R) Antibody |
BNC942868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF594 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC942868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF594 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC802868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC802868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC702868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF770 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC702868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF770 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC882868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF488A conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC882868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF488A conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC812868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC812868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF680R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC402868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF640R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC402868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF640R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC052868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405M conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC052868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405M conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC042868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405S conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC042868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF405S conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNCAP2868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNCAP2868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNCA2868-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), APC conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNCP2868-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), PerCP conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNCR2868-250 |
Biotium |
250uL |
EUR 472.8 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), RPE conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNCH2868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNCH2868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNCB2868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Biotin conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNCB2868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Biotin conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNUB2868-100 |
Biotium |
100uL |
EUR 316.8 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Concentration: 0.2mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNUB2868-50 |
Biotium |
50uL |
EUR 486 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), 1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNUB2868-500 |
Biotium |
500uL |
EUR 615.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), Concentration: 0.2mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC472868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF647 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC472868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF647 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC552868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF555 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC552868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF555 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC612868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF660R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC612868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF660R conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC432868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF543 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC432868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF543 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC682868-100 |
Biotium |
100uL |
EUR 279.6 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF568 conjugate, Concentration: 0.1mg/mL |
Serum Amyloid A (SAA/2868R) Antibody |
BNC682868-500 |
Biotium |
500uL |
EUR 654 |
Description: Primary antibody against Serum Amyloid A (SAA/2868R), CF568 conjugate, Concentration: 0.1mg/mL |
Human Serum Amyloid A (SAA) Protein |
20-abx069044 |
Abbexa |
-
EUR 627.60
-
EUR 292.80
-
EUR 1796.40
-
EUR 727.20
-
EUR 460.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Mouse Serum Amyloid A (SAA) Protein |
20-abx069045 |
Abbexa |
-
EUR 693.60
-
EUR 309.60
-
EUR 2064.00
-
EUR 828.00
-
EUR 510.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Horse Serum Amyloid A (SAA) Protein |
abx670163-01mg |
Abbexa |
0.1 mg |
EUR 1144.8 |
|
Mouse Serum amyloid A-3 protein (Saa3) |
1-CSB-EP361411MO |
Cusabio |
-
EUR 606.00
-
EUR 318.00
-
EUR 2192.40
-
EUR 919.20
-
EUR 1461.60
-
EUR 402.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mouse Serum amyloid A-3 protein(Saa3) expressed in E.coli |
Mouse Serum amyloid A-3 protein (Saa3) |
1-CSB-YP361411MO |
Cusabio |
-
EUR 604.80
-
EUR 318.00
-
EUR 2198.40
-
EUR 915.60
-
EUR 1459.20
-
EUR 400.80
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mouse Serum amyloid A-3 protein(Saa3) expressed in Yeast |
Mouse Serum amyloid A-1 protein (Saa1) |
1-CSB-EP020656MO |
Cusabio |
-
EUR 606.00
-
EUR 318.00
-
EUR 2192.40
-
EUR 919.20
-
EUR 1461.60
-
EUR 402.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mouse Serum amyloid A-1 protein(Saa1) expressed in E.coli |
Mouse Serum amyloid A-2 protein (Saa2) |
1-CSB-EP020657MO |
Cusabio |
-
EUR 606.00
-
EUR 318.00
-
EUR 2192.40
-
EUR 919.20
-
EUR 1461.60
-
EUR 402.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Mouse Serum amyloid A-2 protein(Saa2) expressed in E.coli |
Serum Amyloid A (SAA) Antibody Pair |
20-abx370045 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
Serum Amyloid A (SAA) Antibody Pair |
20-abx370635 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
Serum Amyloid A (SAA) Antibody Pair |
20-abx370785 |
Abbexa |
|
- 10 × 96 tests
- 5 × 96 tests
|
|
Serum Amyloid A (SAA) Antibody (FITC) |
20-abx273736 |
Abbexa |
-
EUR 543.60
-
EUR 292.80
-
EUR 1545.60
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Serum Amyloid A (SAA) Antibody (FITC) |
20-abx273958 |
Abbexa |
-
EUR 543.60
-
EUR 292.80
-
EUR 1579.20
-
EUR 760.80
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Serum Amyloid A (SAA) Antibody (FITC) |
20-abx274059 |
Abbexa |
-
EUR 560.40
-
EUR 292.80
-
EUR 1663.20
-
EUR 777.60
-
EUR 427.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rabbit Serum Amyloid A (SAA) Protein |
20-abx069046 |
Abbexa |
-
EUR 777.60
-
EUR 326.40
-
EUR 2331.60
-
EUR 910.80
-
EUR 560.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rabbit Serum amyloid A-1 protein (SAA1) |
1-CSB-EP020656RB |
Cusabio |
-
EUR 606.00
-
EUR 318.00
-
EUR 2192.40
-
EUR 919.20
-
EUR 1461.60
-
EUR 402.00
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Rabbit Serum amyloid A-1 protein(SAA1) expressed in E.coli |
Human Serum Amyloid A (SAA) Antibody |
13011-05011 |
AssayPro |
150 ug |
EUR 260.4 |
Serum Amyloid A Antibody / SAA1 + SAA2 |
V7516-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody reacts with natural and recombinant human Serum Amyloid A (SAA) and does not cross-react with other human cytokines or growth factors. Human SAA proteins are a group of apo-lipoproteins found predominantly in the high-density lipoprotein (HDL) fraction of plasma. SAA is a major acute-phase protein and precursor to amyloid A protein, which is the major constituent of the fibril deposits of reactive amyloidosis. SAA is secreted in large amounts by the liver during microbial infections or inflammatory diseases. |
Serum Amyloid A Antibody / SAA1 + SAA2 |
V7516-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody reacts with natural and recombinant human Serum Amyloid A (SAA) and does not cross-react with other human cytokines or growth factors. Human SAA proteins are a group of apo-lipoproteins found predominantly in the high-density lipoprotein (HDL) fraction of plasma. SAA is a major acute-phase protein and precursor to amyloid A protein, which is the major constituent of the fibril deposits of reactive amyloidosis. SAA is secreted in large amounts by the liver during microbial infections or inflammatory diseases. |
Serum Amyloid A Antibody / SAA1 + SAA2 |
V7516IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody reacts with natural and recombinant human Serum Amyloid A (SAA) and does not cross-react with other human cytokines or growth factors. Human SAA proteins are a group of apo-lipoproteins found predominantly in the high-density lipoprotein (HDL) fraction of plasma. SAA is a major acute-phase protein and precursor to amyloid A protein, which is the major constituent of the fibril deposits of reactive amyloidosis. SAA is secreted in large amounts by the liver during microbial infections or inflammatory diseases. |
Serum Amyloid A Antibody / SAA1 + SAA2 |
V7516SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody reacts with natural and recombinant human Serum Amyloid A (SAA) and does not cross-react with other human cytokines or growth factors. Human SAA proteins are a group of apo-lipoproteins found predominantly in the high-density lipoprotein (HDL) fraction of plasma. SAA is a major acute-phase protein and precursor to amyloid A protein, which is the major constituent of the fibril deposits of reactive amyloidosis. SAA is secreted in large amounts by the liver during microbial infections or inflammatory diseases. |
Serum Amyloid A Antibody / SAA1 + SAA2 |
V7345-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody reacts with natural and recombinant human Serum Amyloid A (SAA) and does not cross-react with other human cytokines or growth factors. Human SAA proteins are a group of apo-lipoproteins found predominantly in the high-density lipoprotein (HDL) fraction of plasma. SAA is a major acute-phase protein and precursor to amyloid A protein, which is the major constituent of the fibril deposits of reactive amyloidosis. SAA is secreted in large amounts by the liver during microbial infections or inflammatory diseases. |
Serum Amyloid A Antibody / SAA1 + SAA2 |
V7345-20UG |
NSJ Bioreagents |
20 ug |
EUR 153.3 |
Description: This antibody reacts with natural and recombinant human Serum Amyloid A (SAA) and does not cross-react with other human cytokines or growth factors. Human SAA proteins are a group of apo-lipoproteins found predominantly in the high-density lipoprotein (HDL) fraction of plasma. SAA is a major acute-phase protein and precursor to amyloid A protein, which is the major constituent of the fibril deposits of reactive amyloidosis. SAA is secreted in large amounts by the liver during microbial infections or inflammatory diseases. |
Serum Amyloid A Antibody / SAA1 + SAA2 |
V7345IHC-7ML |
NSJ Bioreagents |
7 ml |
EUR 349.3 |
Description: This antibody reacts with natural and recombinant human Serum Amyloid A (SAA) and does not cross-react with other human cytokines or growth factors. Human SAA proteins are a group of apo-lipoproteins found predominantly in the high-density lipoprotein (HDL) fraction of plasma. SAA is a major acute-phase protein and precursor to amyloid A protein, which is the major constituent of the fibril deposits of reactive amyloidosis. SAA is secreted in large amounts by the liver during microbial infections or inflammatory diseases. |
Serum Amyloid A Antibody / SAA1 + SAA2 |
V7345SAF-100UG |
NSJ Bioreagents |
100 ug |
EUR 349.3 |
Description: This antibody reacts with natural and recombinant human Serum Amyloid A (SAA) and does not cross-react with other human cytokines or growth factors. Human SAA proteins are a group of apo-lipoproteins found predominantly in the high-density lipoprotein (HDL) fraction of plasma. SAA is a major acute-phase protein and precursor to amyloid A protein, which is the major constituent of the fibril deposits of reactive amyloidosis. SAA is secreted in large amounts by the liver during microbial infections or inflammatory diseases. |
Serum Amyloid A Antibody / SAA1 + SAA2 |
RQ5313 |
NSJ Bioreagents |
100ul |
EUR 356.15 |
Description: Serum amyloid A (SAA) proteins are a family of apolipoproteins associated with high-density lipoprotein (HDL) in plasma. Different isoforms of SAA are expressed constitutively (constitutive SAAs) at different levels or in response to inflammatory stimuli (acute phase SAAs). These proteins are produced predominantly by the liver. The conservation of these proteins throughout invertebrates and vertebrates suggests that SAAs play a highly essential role in all animals. [Wiki] |
Human Serum amyloid A-4 Protein, SAA4 GENLISA ELISA |
KBH6165 |
Krishgen |
1 x 96 wells |
EUR 286 |
Serum Amyloid A (SAA) Antibody (Biotin) |
20-abx272067 |
Abbexa |
-
EUR 510.00
-
EUR 276.00
-
EUR 1429.20
-
EUR 693.60
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Serum Amyloid A (SAA) Antibody (Biotin) |
20-abx272757 |
Abbexa |
-
EUR 510.00
-
EUR 276.00
-
EUR 1462.80
-
EUR 710.40
-
EUR 393.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Serum Amyloid A (SAA) Antibody (Biotin) |
20-abx273039 |
Abbexa |
-
EUR 543.60
-
EUR 292.80
-
EUR 1545.60
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Serum Amyloid A (SAA) Antibody (Biotin) |
20-abx274604 |
Abbexa |
-
EUR 410.40
-
EUR 243.60
-
EUR 1028.40
-
EUR 526.80
-
EUR 343.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Serum Amyloid A-1 Protein (SAA1) Protein |
20-abx260404 |
Abbexa |
-
EUR 276.00
-
EUR 2665.20
-
EUR 393.60
|
|
|
Human Serum Amyloid A-1 Protein (SAA1) Protein |
20-abx263470 |
Abbexa |
-
EUR 276.00
-
EUR 2013.60
-
EUR 393.60
|
|
|
ELISA kit for Human Serum amyloid A-4 protein (SAA4) |
KTE60753-48T |
Abbkine |
48T |
EUR 398.4 |
|
Description: Quantitative sandwich ELISA for measuring Human Serum amyloid A-4 protein (SAA4) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Serum amyloid A-4 protein (SAA4) |
KTE60753-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2538 |
|
Description: Quantitative sandwich ELISA for measuring Human Serum amyloid A-4 protein (SAA4) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Human Serum amyloid A-4 protein (SAA4) |
KTE60753-96T |
Abbkine |
96T |
EUR 646.8 |
|
Description: Quantitative sandwich ELISA for measuring Human Serum amyloid A-4 protein (SAA4) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
The CRISPR neighborhood due to this fact should actively have interaction with these worldwide deliberations, society, and nationwide governance methods which have promised to construct higher agricultural methods and present higher meals merchandise to realize equitable outcomes whereas defending the surroundings. Without this energetic engagement, the guarantees mentioned in this paper are certain to be damaged.